Adding a layer of compute to connect two massive datasets is where we are headed. Mike Nalls, Hampton Leonard, Matt Bookman, and Eline Appelmans outline the partnership between The Global Parkinson’s Genetics Program (GP2) and Accelerating Medicines Partnership: Parkinson's Disease (AMP PD) to be your one-stop shop for PD genetic and genomic data in this new blog post. The post GP2 and AMP PD: Platform Partners for Progress in Parkinson’s Research appeared first on Aligning Science Across...| Aligning Science Across Parkinson's
In GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to access and use. The latest blog post by Bradford Casey highlights the value and importance of open science. The post Open Science Opens Doors appeared first on Aligning Science Across Parkinson's.| Aligning Science Across Parkinson's
ASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, shared by patient advocate Benjamin Stecher.| Aligning Science Across Parkinson's
Training is a crucial element of GP2. In this blog post, Alastair Noyce, Sara Bandres-Ciga and Emily Fisher outline the program's training and development goals.| Aligning Science Across Parkinson's